JP2019509999A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509999A5
JP2019509999A5 JP2018543712A JP2018543712A JP2019509999A5 JP 2019509999 A5 JP2019509999 A5 JP 2019509999A5 JP 2018543712 A JP2018543712 A JP 2018543712A JP 2018543712 A JP2018543712 A JP 2018543712A JP 2019509999 A5 JP2019509999 A5 JP 2019509999A5
Authority
JP
Japan
Prior art keywords
asc
use according
culture
growth medium
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018543712A
Other languages
English (en)
Japanese (ja)
Other versions
JP6884792B2 (ja
JP2019509999A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/050868 external-priority patent/WO2017141181A1/en
Publication of JP2019509999A publication Critical patent/JP2019509999A/ja
Publication of JP2019509999A5 publication Critical patent/JP2019509999A5/ja
Application granted granted Critical
Publication of JP6884792B2 publication Critical patent/JP6884792B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018543712A 2016-02-18 2017-02-16 がん及び新生物の治療方法及び治療用組成物 Expired - Fee Related JP6884792B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662296621P 2016-02-18 2016-02-18
US62/296,621 2016-02-18
PCT/IB2017/050868 WO2017141181A1 (en) 2016-02-18 2017-02-16 Methods and compositions for treating cancers and neoplasms

Publications (3)

Publication Number Publication Date
JP2019509999A JP2019509999A (ja) 2019-04-11
JP2019509999A5 true JP2019509999A5 (https=) 2020-03-26
JP6884792B2 JP6884792B2 (ja) 2021-06-09

Family

ID=58266008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018543712A Expired - Fee Related JP6884792B2 (ja) 2016-02-18 2017-02-16 がん及び新生物の治療方法及び治療用組成物

Country Status (7)

Country Link
US (1) US20210205370A1 (https=)
EP (1) EP3416662B1 (https=)
JP (1) JP6884792B2 (https=)
AU (1) AU2017220148A1 (https=)
CA (1) CA3012741A1 (https=)
IL (1) IL261146B (https=)
WO (1) WO2017141181A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018191619A1 (en) 2017-04-13 2018-10-18 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
US20210000882A1 (en) * 2018-02-28 2021-01-07 Crown Scientific, LLC Production and use of extracellular vesicles
US20210115395A1 (en) * 2018-03-28 2021-04-22 Pluristem Ltd. Methods for expanding adherent stromal cells and cells obtained thereby
JP7538044B2 (ja) * 2018-04-30 2024-08-21 ザ チルドレンズ メディカル センター コーポレーション 間葉系間質細胞エキソソームおよびそれらの使用
US11419898B2 (en) 2018-10-17 2022-08-23 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
AU2019359890B2 (en) * 2018-10-17 2024-10-24 Senti Biosciences, Inc. Combinatorial cancer immunotherapy
US20220323412A1 (en) * 2019-09-06 2022-10-13 Chi-Chih Kang Extracellular vesicle-fenretinide compositions, extracellular vesicle-c-kit inhibitor compositions, methods of making and uses thereof
WO2022059026A1 (en) * 2020-09-21 2022-03-24 Mestastop Solutions Private Limited Systems and methods for predicting cancer metastasis and screening of drugs
JP7849911B2 (ja) * 2021-09-27 2026-04-22 金湧長生醫學生物科技股▲ふん▼有限公司 脱落膜胎盤間葉系幹細胞及び血管新生促進医薬組成物の製造におけるその用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
JPS6410979A (en) 1987-07-03 1989-01-13 Mitsubishi Chem Ind Microcarrier for cultivating cell
US5629186A (en) 1994-04-28 1997-05-13 Lockheed Martin Corporation Porous matrix and method of its production
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
DE69903800T2 (de) 1998-03-18 2003-10-02 Massachusetts Institute Of Technology, Cambridge Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane
US6153432A (en) 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
EP1261694B1 (en) 2000-02-26 2008-01-16 Artecel, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
WO2007011693A2 (en) * 2005-07-14 2007-01-25 Medistem Laboratories, Inc. Compositions of placentally-derived stem cells for the treatment of cancer
EP2366775B1 (en) 2006-03-23 2015-04-22 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US7531334B2 (en) 2006-04-14 2009-05-12 Xerox Corporation Polymeric microcarriers for cell culture functions
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
MX2010003019A (es) * 2007-09-19 2010-04-30 Pluristem Ltd Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
NZ599825A (en) * 2007-09-28 2014-10-31 Anthrogenesis Corp Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US8828720B2 (en) 2008-03-17 2014-09-09 Agency For Science, Technology And Research Microcarriers for stem cell culture
CN105708862B (zh) * 2008-09-02 2020-11-06 普拉里斯坦有限公司 来自胎盘组织的粘附细胞及其在治疗中的用途
EP3150703A1 (en) 2009-07-09 2017-04-05 TiGenix, S.A.U. Cells for use in a method for treating inflammatory and/or immune disorders
EP2977445B1 (en) 2009-11-30 2018-07-25 Pluristem Ltd. Adherent cells from placenta and use of same in disease treatment
DK3284818T3 (da) * 2010-01-26 2022-06-20 Celularity Inc Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
EP2561066B1 (en) * 2010-04-23 2016-03-30 Pluristem Ltd. Adherent stromal cells derived from plancentas of multiple donors and uses thereof
CN103476924A (zh) 2011-04-15 2013-12-25 普拉里斯坦有限公司 收获细胞的方法和系统
RU2615179C2 (ru) 2012-09-06 2017-04-04 Плуристем Лтд. Устройства и способы культивирования клеток
WO2014066122A1 (en) * 2012-10-24 2014-05-01 The Texas A&M University System Treatment of tumors with activated mesenchymal stem cells
US10258652B2 (en) 2014-12-18 2019-04-16 Pluristem Ltd. Methods and compositions for treating and preventing muscle wasting disorders
US20180015125A1 (en) 2015-03-23 2018-01-18 Pluristem Ltd. Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof

Similar Documents

Publication Publication Date Title
JP2019509999A5 (https=)
JP2017537625A5 (https=)
JP2011125348A5 (https=)
CN102911918A (zh) 一种基因工程细胞及其在nk细胞扩增中的应用
JP2012521215A5 (https=)
CN205170866U (zh) 一种无透明带胚胎培养皿
EP4234019A3 (en) Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
JP2017508479A5 (https=)
SG10201902355VA (en) Ultra-high density cell banking methods
JP2016539641A5 (https=)
JP2014508527A5 (https=)
SI1554374T1 (sl) Postopek za masovno gojenje kultur limfocitov v homogenem sistemu
JPWO2024071212A5 (https=)
TWD212795S (zh) 半導體處理設備用電極
CN106431658B (zh) 一种平菇培养基及平菇栽培方法
TWD219557S (zh) 基板處理設備用反應器壁
CN115087729A (zh) 赤红球菌细胞壁骨架在再生医学中的用途
CN110799641A (zh) 丁酸钠的用途及含有丁酸钠的培养体系
CN206956055U (zh) 用于原代细胞培养的软组织切割器
CN207091432U (zh) 一种可调角度、通气的干细胞培养装置
CN106867903A (zh) 一种用于原代细胞培养的软组织切割器
CN204325367U (zh) 细胞密度依赖性生长抑制检测装置
CN105015136A (zh) 一种塑胶产品表面贴膜治具
CN204748913U (zh) 一种筒形耐火砖夹紧装置
CN205727248U (zh) 五室植物培养装置